MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis

被引:15
|
作者
Chen, Liangyuan [1 ]
Cui, Zhaolei [1 ]
Liu, Yaohua [1 ]
Bai, Ye [1 ]
Lan, Fenghua [1 ]
机构
[1] Fuzhou Gen Hosp, Dept Clin Genet & Expt Med, Fuzhou, Fujian, Peoples R China
关键词
bladder cancer; meta-analysis; microRNA; diagnosis; EXPRESSION PROFILES; TUMOR-MARKERS; URINE; IDENTIFICATION; SENSITIVITY; STATISTICS; TESTS; RNA;
D O I
10.7754/Clin.Lab.2015.150204
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Bladder cancer (BCa) is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs (miRNAs) are emerging as diagnostic biomarkers for BCa. However, the findings in these studies are inconsistent. To systematically assess the potential diagnostic value of miRNAs for BCa, a meta-analysis was performed in this study. Methods: Relevant literature was researched in PubMed, Embase, Cochrane Library, Chinese National Knowledge Infrastructure (CNKI), and WanFang databases up to September 1, 2014. The pooled sensitivity, specificity, positive likelihood ratio (PLR), negative LR (NLR), diagnostic odds ratio (DOR), and area under the SROC curve (AUC) value were analyzed by the random-effects model, whose parameters reflected the overall diagnostic performance of miRNAs. Results: Thirty studies from 10 individual publications, including 1019 BCa patients and 690 controls, were included in this meta-analysis. The pooled sensitivity, specificity, PLR, NLR, DOR, and AUC were 0.80 (95% CI: 0.78 - 0.81), 0.74 (95% CI: 0.72 - 0.76), 3.22 (95% CI: 2.68 - 3.87), 0.26 (95% CI: 0.21 - 0.32), 15.20 (95% CI: 10.25 - 22.53) and 0.85, respectively, indicating a moderate diagnostic accuracy for BCa. Moreover, our subgroup analyses showed that analysis of multiple miRNAs (AUC, sensitivity, and specificity of 0.913, 0.86, and 0.80, respectively) yielded a higher diagnostic accuracy than of single miRNAs (AUC, sensitivity, and specificity of 0.84, 0.78, and 0.73, respectively) in BCa diagnosis. In addition, as biomarkers, miRNAs are more suitable for the diagnosis of non-muscle-invasive BCa (NMIBCa) with AUC of 0.84, sensitivity of 0.74, and specificity of 0.77 than muscle-invasive BCa (MIBCa) with AUC of 0.79, sensitivity of 0.73, and specificity of 0.73. Conclusions: The present meta-analysis suggests that miRNAs are potential novel biomarkers for detection of BCa. However, further validation studies are still needed to confirm our findings.
引用
收藏
页码:1101 / 1108
页数:8
相关论文
共 50 条
  • [31] Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis
    Zhao, Liming
    Li, Jun
    Xue, Zhongguang
    Wang, Jinfeng
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (06): : 1497 - 1507
  • [32] Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer
    Peng, Cheng
    Wang, Jiale
    Gao, Wenzhe
    Huang, Lihua
    Liu, Yunfei
    Li, Xia
    Li, Zhiqiang
    Yu, Xiao
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (03): : 660 - 671
  • [33] CircRNAs as biomarkers of cancer: a meta-analysis
    Wang, Miao
    Yang, Yuxi
    Xu, Jian
    Bai, Wen
    Ren, Xueli
    Wu, Huijian
    BMC CANCER, 2018, 18
  • [34] Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis
    Thu H. N. Nguyen
    Thanh T. N. Nguyen
    Tran T. M. Nguyen
    Le H. M. Nguyen
    Luan H. Huynh
    Hoang N. Phan
    Hue T. Nguyen
    Breast Cancer Research and Treatment, 2022, 196 : 1 - 15
  • [35] MicroRNAs as Potential Biomarkers for the Diagnosis of Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Li, Jing
    Ma, Leilei
    Yu, Hangxing
    Yao, Yahong
    Xu, Zhiyuan
    Lin, Wei
    Wang, Lin
    Wang, Xuejun
    Yang, Hongtao
    FRONTIERS IN MEDICINE, 2022, 8
  • [36] Identification of microRNAs as novel biomarkers for glioma detection: A meta-analysis based on 11 articles
    Qu, Shengtao
    Guan, Junhong
    Liu, Yunhui
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 348 (1-2) : 181 - 187
  • [37] Nuclear matrix protein 22 (NMP22) test in the diagnosis of bladder cancer: a meta-analysis
    Fu, Lei
    Wang, Rong
    Yin, Ling
    Zhang, Pengjun
    Tian, Yaping
    Niu, Maochang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 7965 - 7975
  • [38] MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis
    Sun, Lina
    Han, Yanan
    Wang, Hua
    Liu, Huanyu
    Liu, Shan
    Yang, Hongbin
    Ren, Xiaoxia
    Fang, Ying
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (04)
  • [39] MicroRNAs as a Novel Class of Diagnostic Biomarkers in Detection of Oral Carcinoma: a Meta-Analysis Study
    Lin, Ni
    Lin, Yazhen
    Fu, Xiaodan
    Wu, Chuncai
    Xu, Jianping
    Cui, Zhaolei
    Lin, Donghong
    CLINICAL LABORATORY, 2016, 62 (03) : 451 - 461
  • [40] MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis
    Deng, Han-Yu
    Li, Gang
    Luo, Jun
    Wang, Zhi-Qiang
    Yang, Xiao-Yan
    Lin, Yi-Dan
    Liu, Lun-Xu
    JOURNAL OF THORACIC DISEASE, 2016, 8 (12) : 3580 - 3587